Related Experiment Video
Updated: Jul 20, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
[Moyamoya disease]
P G Peña-Tapia1, P Horn, P Schmiedek
1Servico de Neurocirugía. Hospital Universitario Mannheim. Universidad de Heidelberg. Mannheim, Alemania. pablo.pena@nch.ma
Aims:
To describe the clinical manifestations and to summarise the knowledge currently available about the epidemiology, physiopathology, histopathology, diagnosis and treatment of moyamoya disease.
Development:
Moyamoya disease is produced by the spontaneous, progressive occlusion of the circle of Willis with the simultaneous appearance of natural intracranial and extra-intracranial collaterals. Both children and adults can be affected and it is to be found not only in Asia but also in Europe and America, although the frequency is unknown. Its primary lesion is a thickening of the tunica interna in the distal segment of the internal carotids, initially within the anterior portion of the circle of Willis. This results in the appearance of collateral vessels, which are first intracranial (moyamoya vessels) and then extracranial, to offset the critical reduction in regional cerebral blood flow. The most common clinical manifestation is motor-type ischaemic episodes, although it may also be accompanied by intracerebral haemorrhages. It can be diagnosed by means of suitable morphological and functional studies, such as cerebral pan angiography and xenon-CT, in patients with a founded clinical suspicion. Neurosurgical revascularisation is to date the most widely accepted treatment and can bring about a permanent clinical cure.
Conclusions:
Moyamoya disease is a rare pathology that can be successfully treated using cerebral revascularisation, provided a timely diagnosis is reached and in indicated patients. Such therapy makes it possible to prevent the repetition of ischaemic events or haemorrhages that usually bring about severe limitations in the individual's personal development.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
06:04Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe
Published on: August 16, 2024
Related Concept Videos
Huntington Disease l: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Coronary Artery Disease II: Pathophysiology
Cerebral Edema ll: Pathophysiology
Alzheimer Disease ll: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy